People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tissuetech, Inc. | — | Biotechnology | Series C | $83.0M | $2.3B | 2019 |
Michael C.G. Cornelinus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael C.G. Cornelinus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carter McNabb | 1 | 10 |
| Matt Rice | 1 | 5 |
| Greg Collins | 1 | 4 |
| Jane Hsiao | 1 | 3 |
| Jane K. Hsiao | 1 | 1 |
| Greg K. Collins | 1 | 1 |
| Carter K. McNabb | 1 | 1 |
| Matt K. Rice | 1 | 1 |
| Billy Yeh | 1 | 1 |
| Scheffer Tseng | 1 | 1 |
| Amy Tseng | 1 | 1 |
| MICHAEL K. CORNELIUS | 1 | 1 |
| DEVIN K. BUCKLEY | 1 | 1 |
| Brian C.G. Yeh | 1 | 1 |
| Martin C.G. Nutter | 1 | 1 |
| Devin C.G. Buckley | 1 | 1 |
| Matt C.G. Rice | 1 | 1 |
| John C.G. Arnott | 1 | 1 |
| William C.G. Hawkins | 1 | 1 |
| Billy K. Yeh | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.